What drugs does LOXO ONCOL make?

LOXO ONCOL has 1 FDA-approved drugs including JAYPIRCA.

What therapeutic areas does LOXO ONCOL focus on?

LOXO ONCOL focuses primarily on Oncology and Metabolic and 1 other therapeutic areas.

← Back

Data updated: Mar 10, 2026

LOXO ONCOL

OncologyMetabolicNeurology

Pharma

LOXO ONCOL is a pharmaceutical company focused on Oncology, Metabolic, Neurology. Key products include JAYPIRCA.

2023

Since

Drugs

Trials

Approved (2yr)

Key Drugs

JAYPIRCA

pirtobrutinib

Oncology

BTK 3 indications · 2023

Recent Activity

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 85%

1 drugs Phase 3: 6 Phase 2: 1 Phase 1: 1

Metabolic 10%

0 drugs Phase 3: 1

Neurology 5%

0 drugs Phase 2: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

Eli Lilly big-pharma

Metabolic, Oncology, Neurology

Takeda big-pharma

Oncology, Neurology, Metabolic

Novo Nordisk big-pharma

Metabolic, Oncology, Neurology

Amgen biotech

Oncology, Metabolic, Neurology

EMD SERONO INC biotech

Oncology, Neurology, Metabolic

LOXO ONCOL

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (1)

Active (1)

Discontinued (0)

Company Info